Ian R. Hardie

THE RISK OF SKIN CANCER IN RENAL TRANSPLANT RECIPIENTS IN QUEENSLAND, AUSTRALIA

Jan Nico Bouwes Bavinck, David R. Hardie, Adèle C. Green et al. · Transplantation · 1996 · 501 citations

Medicine, Dermatology, Oncology +16

REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1

Susan Light, Ian R. Hardie, Amy Lin et al. · Transplantation · 1999 · 308 citations

Life Sciences, Nephrology, Pharmacotherapy +17

Skin cancer in Caucasian renal allograft recipients living in a subtropical climate.

Ian R. Hardie, Russell W. Strong, L. Hartley et al. · PubMed · 1980 · 227 citations

Medicine, Dermatology, Oncology +16

Comparison of Three Immunosuppressive Regimens in Cadaver Renal Transplantation: Long-Term Cyclosporine, Short-Term Cyclosporine Followed by Azathioprine and Prednisolone, and Azathioprine and Prednisolone without Cyclosporine

Bruce M. Hall, David J. Tiller, Ian R. Hardie et al. · New England Journal of Medicine · 1988 · 128 citations

Medicine, Nephrology, Kidney Transplantation +16

RESULTS OF 3-YEAR PHASE III CLINICAL TRIALS WITH DACLIZUMAB PROPHYLAXIS FOR PREVENTION OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION1

Ginny L. Bumgardner, Ian R. Hardie, Robert W. Johnson et al. · Transplantation · 2001 · 103 citations

Medicine, Nephrology, Pharmacology +17